Clinical Trials Logo

Clinical Trial Summary

Bone density is recognized as the most important factor to measure osteoporosis, and the prevalence of osteoporosis increases with age. Risk factors for osteoporosis include age, weight, exercise, diet, smoking and alcohol consumption. What's more, osteoporosis has a strong familial aggregation, and the genetic value of bone density is between 0.6 and 0.85. Therefore, it is necessary to conduct large-scale collection of population samples of osteoporosis fractures and relevant genetic studies.


Clinical Trial Description

From past linkage analysis and candidate gene association studies to genome-wide association studies and second-generation sequencing technologies, researchers have found hundreds of genes and SNPs associated with bone mineral density and osteoporosis fractures. However, current studies on osteoporosis and related phenotypes are mainly concentrated in the European and American populations, rare in Asia and other regions, and even less in the Chinese han population. It is one of the problems to be solved in this project whether the genes and SNP loci associated with these strengths can also be applied to han Chinese population due to the existence of racial differences. This project aims to collect the patients with primary osteoporosis and osteoporosis fracture in the Chinese han population through the orthopaedics department, and verify the identified osteoporosis susceptibility genes in the Chinese han population. ;


Study Design


Related Conditions & MeSH terms

  • Osteoporosis
  • Senile Osteoporosis With Current Pathological Fracture Lower Leg (Diagnosis)

NCT number NCT04129671
Study type Observational
Source Second Affiliated Hospital, School of Medicine, Zhejiang University
Contact Shigui Yan, Doctore
Phone 057187783530
Email Olivery@zju.edu.cn
Status Recruiting
Phase
Start date April 29, 2019
Completion date December 31, 2021